走向辅助生殖中的动态卵巢募集表型:基于卵泡身份追踪的可验证框架
Toward a Dynamic Ovarian Recruitment Phenotype in Assisted Reproduction
摘要
该预印本为观点性文章,提出“动态卵巢募集表型”概念:以受治疗条件约束、跨超声扫描保持同一窦卵泡身份的生长轨迹描述,替代仅按单次就诊汇总的指标,并强调它并非原始卵泡储备库的新测量。作者给出可证伪假设——在相同早期预测节点,基线变量与完整常规监测信息之外,卵泡身份关联的生长、持续性与同步性仍能提供成熟卵母细胞获取数的可重复增量信息;据此设计三个嵌套模型比较,加入秩匹配伪身份模型与身份置换阴性对照,并检验轨迹特征能否跨周期保留患者层面成分。全文未提供新临床数据。
原文摘要
Anti-Müllerian hormone (AMH) and antral follicle count (AFC) predict ovarian response, while serial ultrasound documents the evolving antral cohort during controlled stimulation. Yet most visit-level summaries do not preserve which follicle is which across scans. We propose a dynamic ovarian recruitment phenotype, defined as a treatment-conditioned description of identity-linked antral follicle trajectories rather than a new measure of primordial reserve. Our primary, falsifiable hypothesis is that individual follicle identity contributes reproducible information about mature-oocyte yield beyond baseline predictors and the complete routine monitoring history available at the same early prediction landmark. A stringent test compares three nested models: baseline characteristics; baseline plus contemporaneous visit-level measurements, hormones and treatment exposure; and the same information augmented by identity-linked growth, persistence and synchrony, with a rank-matched pseudo-identity model as an intermediate comparator. Scans, prediction timing and modelling flexibility must be matched, with identity permutation as a negative control. A separate hypothesis asks whether any trajectory feature retains a patient-level component across comparable stimulation cycles. Spatial features are exploratory and are not evidence of primordial-follicle activation. Support requires reliable tracking, external validation, clinically relevant incremental prediction and, ultimately, evidence of benefit for a specific clinical decision. Equal performance of identity-free monitoring models, sensitivity to matching error or absent cross-cycle reproducibility would substantially weaken the proposed phenotype. This essay offers an operational definition and a validation pathway, not new clinical data or treatment recommendations.
推荐理由:把“卵泡身份跨扫描追踪”提升为可操作的候选表型,并给出含阴性对照与外部验证的严格验证路径,对做卵巢反应预测建模与超声监测数字化的团队有方法学参考价值;但属观点性预印本,无新数据,临床可用性尚待验证。
文献解读
尚未生成。